GR
GRCU.US Green Cures & Botanical Distribution Inc
- Market cap
- USD 723K
- P/E
- -
- P/B
- -
- ROE
- -37.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2024.
Is GRCU.US undervalued?
Graham numberThe Graham number of Green Cures & Botanical Distribution Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Green Cures & Botanical Distribution Inc fundamental analysis
No fundamental analysis for Green Cures & Botanical Distribution Inc yet.
Green Cures & Botanical Distribution Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Green Cures & Botanical Distribution Inc
Global Roundtable Corporation provides health and wellness services and products. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.
Full company profileGreen Cures & Botanical Distribution Inc financial statements
Green Cures & Botanical Distribution Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 20.2K | 6.80K | 113K | 143K | 183K | 192K | 136K | 102K | 2.36M | 1.30M |
| Gross Profit | -10.5K | 2.38K | 87.5K | 119K | 154K | 143K | 8.59K | 74.6K | 1.39M | 479K |
| Operating Income | -95.6K | -2.77M | 55.8K | 71.0K | 63.1K | 21.9K | -509K | -430K | 521K | -226K |
| EBITDA | -95.6K | -2.77M | 80.6K | 98.0K | 63.1K | 21.9K | -509K | -415K | 549K | -186K |
| Net Income | -95.6K | -2.78M | 51.6K | 66.7K | 63.1K | 10.1K | -521K | -452K | 409K | -243K |
| EPS | -0.01 | -0.01 | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 69.7K | 406.00 | 996.00 | 4.82K | 3.89K | 527K | 627K | 608K | 1.75M | 2.03M |
| Total Liabilities | 83.2K | 311K | 322K | 373K | 27.9K | 470K | 632K | 806K | 1.03M | 1.38M |
| Shareholders' Equity | -13.4K | -311K | -321K | -43.7K | -24.1K | 57.3K | 4.77K | -198K | 734K | 656K |
| Cash & Short-term Investments | 500.00 | 406.00 | 996.00 | 4.82K | 3.89K | 3.11K | 10.3K | -365.00 | 206K | 363K |
| Total Debt | 54.0K | 206K | 225K | 171K | 20.5K | 470K | 606K | 738K | 364K | 373K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -57.0K | 2.35K | -154K | -14.8K | -282K | -4.25K | -216K | -118K | 32.4K | 32.6K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 517K | 0.00 | 0.00 | 2.00 | 2.00 |
| Free Cash Flow | -57.0K | 2.35K | -154K | -14.8K | -282K | -521K | -216K | -118K | 32.4K | 32.6K |
| Ratios | ||||||||||
| ROE | - | - | - | - | - | 17.7% | -10,921.8% | - | 55.7% | -37.1% |
| ROA | -137.1% | -684,617.2% | 5,181.5% | 1,385.1% | 1,622.8% | 1.9% | -83.0% | -74.3% | 23.3% | -12.0% |
| Net Profit Margin | -473.4% | -40,875.7% | 45.7% | 46.8% | 34.5% | 5.3% | -383.3% | -442.8% | 17.4% | -18.7% |
| Debt to Equity | - | - | - | - | - | 8.21x | 127.10x | - | 0.50x | 0.57x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Green Cures & Botanical Distribution Inc dividends
Green Cures & Botanical Distribution Inc has not paid dividends in the last 10 fiscal years.
Last stock split: 1:130 on Jan 8, 2016.
Who owns Green Cures & Botanical Distribution Inc
- Insiders 0.00%
- Institutions 0.02%
- Public & others 99.98%
- Shares outstanding 7.23B
Green Cures & Botanical Distribution Inc company profile
- Company name
- Green Cures & Botanical Distribution Inc
- Ticker
- GRCU.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 20
- Fiscal year end
- December
- Address
- 7535 East Avenue, Denver, CO, United States, 80231
- Phone
- 845-390-0673
- Website
- greencurescorp.com
About Green Cures & Botanical Distribution Inc
Global Roundtable Corporation provides health and wellness services and products. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.
Green Cures & Botanical Distribution Inc management
5- Mr. Rich ThomasChief Executive Officer
- Mr. Michael LajtayPresident, Chief Operating Officer and Lead Product Developer
- Mr. Benjamin CraikChief Technology Officer
- Mr. David MoceriChief Marketing Officer
- Mr. Joseph TragesserConsultant & Advisor